Your session is about to expire
← Back to Search
Study Summary
This trial is being conducted at multiple locations in the US. It is a study that involves patients who are getting surgery to remove cataracts and replace their lenses. The study compares the effects of different
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
In how many medical institutions is this clinical examination currently being conducted?
"This trial is being conducted at the Cincinnati Eye Institute in Cincinnati, Ohio, as well as the United Medical Research Institute in Inglewood, California, and North Bay Eye Associates in Petaluma, Colorado. Additionally, there are 9 other locations where this trial will take place."
What is the current number of individuals who have been granted admission to participate in this clinical study?
"To proceed with the study, we need a total of 90 eligible participants who meet the trial's inclusion criteria. The sponsor, VivaVision Biotech, Inc., will be overseeing the trial across various locations including Cincinnati Eye Institute in Cincinnati, Ohio and United Medical Research Institute in Inglewood, California."
What are the potential risks and hazards associated with the usage of VVN461 1.0% by individuals?
"Based on our assessment, the safety rating for VVN461 1.0% is a 2 as per Power's scale. This determination is due to it being in Phase 2 of the trial, where some data supports its safety but there is no evidence yet regarding efficacy."
Are there any open slots available for new patients to participate in this research study at the moment?
"Indeed, the details presented on clinicaltrials.gov confirm that this trial is actively seeking eligible candidates. The initial posting took place on January 1st, 2024 and was most recently edited on December 19th, 2023. To complete the study successfully, a total of 90 participants will be recruited from nine different sites."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger